Get started
Author

Francisco José García Verdejo

Observed names: F Verdejo, F.J. Garcia Verdejo, F.J. García Verdejo, F.J.G. Verdejo, Francisco García Verdejo, Francisco J. García Verdejo
OpenAlex ID: A5006862278
Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization
2023 · Esther Clavero, José Manuel Sanchez-Maldonado, et al. · International Journal of Molecular Sciences · 18
Thrombosis in breast cancer patients on cyclin-dependent kinase inhibitors: Survival impact and predictive factors - A study by the cancer and thrombosis group of the spanish society of medical oncology (SEOM)
2024 · Manuel Sánchez Cánovas, Javier López Robles, et al. · European Journal of Internal Medicine · 6
PDF
Immune checkpoint inhibitors-associated thrombosis in patients with head and neck cancer: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group
2024 · Manuel Sánchez Cánovas, Miguel Ángel Moya Hernández, et al. · Clinical & Translational Oncology · 3
PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group
2025 · Manuel Sánchez Cánovas, Javier López Robles, et al. · Clinical & Translational Oncology · 2
PDF
2145P Thromboembolic disease associated with cyclin-dependent kinase inhibitors in patients with breast cancer
2023 · J. López Robles, E. Adoamnei, et al. · Annals of Oncology · 1
PDF
Hemangioma hepático gigante tratado con embolización
2019 · L. Díaz-Rubia, Francisco José García Verdejo · Revista Andaluza de Patología Digestiva · 1
Survival with nivolumab therapy in recurrent/advanced squamous cell head and neck carcinoma. A single center experience.
2018 · Ana Laura Ortega Granados, Natalia Luque Caro, et al. · Journal of Clinical Oncology · 1
Venous and arterial thromboembolic events associated with osimertinib in patients with lung cancer: a study by the thrombosis and cancer group of the spanish society of medical oncology (SEOM)
2026 · Manuel Sánchez Cánovas, Javier López Robles, et al. · Clinical & Translational Oncology
PDF
Current patterns of next-generation sequencing implementation in hepatocellular carcinoma in Spain
2026 · Luis Cabezón Gutiérrez, Carlos López López, et al. · Clinical & Translational Oncology
Correction: PARP inhibitors‑associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group
2025 · Manuel Sánchez Cánovas, Javier López Robles, et al. · Clinical & Translational Oncology
PDF
2841P Real-world incidence and predictors of thromboembolic events in lung cancer patients treated with osimertinib
2025 · J. López Robles, M. Sanchez Canovas, et al. · Annals of Oncology
1861P Poly (ADP-Ribose) polymerase inhibitors (PARPI): Associated thrombosis in patients with ovarian cancer
2024 · M. Sanchez Canovas, J. López Robles, et al. · Annals of Oncology
PDF
153P Descriptive analysis of the location of point mutations in BRCA and the risk of breast or ovarian cancer diagnosis
2023 · P. Torres-Mozas, F. Galvez Montosa, et al. · Annals of Oncology
PDF
Patients characteristics, treatment patterns and clinical outcomes in patients with head and neck squamous cell carcinoma (aHNSCC) receiving immunotherapy in advanced setting: Retrospective cohort analysis of real-world data in Spain.
2023 · Ana Laura Ortega Granados, German Paolo Vinueza, et al. · Journal of Clinical Oncology
Biloma gigante tras hepatectomía en paciente con cáncer de colon metastásico
2019 · L. Díaz-Rubia, Francisco José García Verdejo · Revista Andaluza de Patología Digestiva
Hematoma subcapsular hepático como inusual complicación tras realización de CPRE en paciente con colangiocarcinoma
2019 · L. Díaz-Rubia, Francisco José García Verdejo, et al. · Revista Andaluza de Patología Digestiva
Afectación glomerular con patrón membranoproliferativo asociado a inmunocomplejos y microangiopatía trombótica tras tratamiento con bevacizumab: significado patogénico de los depósitos inmunes e implicaciones para el diagnóstico diferencial
2017 · Francisco José Borrego Utiel, Rocío Solórzano Mariscal, et al. · Nefroplus
P1.07-036 LC-HRMS Metabolomics Profiling in Advanced NSCLC Treated with Anti PD-1 Agents. Metabolic Features at Diagnosis and at Response Evaluation
2017 · A.L. Ortega Granados, F.J. García Verdejo, et al. · Journal of Thoracic Oncology
Histological features and survival in NSCLC patients treated with surgery with curative intention.
2017 · Nuria Cárdenas Quesada, Ana Laura Ortega Granados, et al. · Journal of Clinical Oncology
A metabolomic signature for predicting chemosensitivity in gastric cancer.
2017 · Francisco José García Verdejo, Ana Laura Ortega Granados, et al. · Journal of Clinical Oncology
Differences in survival between usual practice and clinical trial participants in advanced NSCLC by age.
2017 · Ana Laura Ortega Granados, Nuria Cárdenas Quesada, et al. · Journal of Clinical Oncology
LC-hrms metabolomics profiling in breast cancer: Searching for biomarkers in human plasma samples.
2017 · Pedro Sánchez Rovira, Ana Laura Ortega Granados, et al. · Journal of Clinical Oncology
P1.07-009 Outcomes of Patients with Relapsed Small-Cell Lung Cancer Treated with Paclitaxel plus Gemcitabine. 10 Year-Analysis
2017 · Ana Laura Ortega Granados, Natalia Luque Caro, et al. · Journal of Thoracic Oncology
PDF
P2.03a-047 Clinical Trial Participation and Outcomes in Non-Small Cell Lung Cancer: Case-Control Study
2017 · Ana Laura Ortega Granados, Capilla De La Torre Cabrera, et al. · Journal of Thoracic Oncology
Paciente con hemocolecisto traumático por coz de caballo
2017 · Laura Díaz Rubia, Yolanda Núñez Delgado, et al. · Revista Andaluza de Patología Digestiva
Works count: 29
Citation count: 32
H-index: 3
I10-index: 1
Year
Topic
Type